Natures Valley Collagen Builder tablets
AustraliaNatures Valley Collagen Builder tablets
Recalling Firm: TGA
Reason for Recall / Hazard
The Therapeutic Goods Administration (TGA) is advising consumers that Natures Valley Collagen Builder tablets may pose a serious risk to your health and should not be taken....
Product Description & Identification
The Therapeutic Goods Administration (TGA) is advising consumers that Natures Valley Collagen Builder tablets may pose a serious risk to your health and should not be taken.
Affected Products
Natures Valley Collagen Builder tablets
Additional Source Details
| Field | Value |
|---|---|
| Guid › #text | https://www.tga.gov.au/node/550084 |
| Guid › @ is Perma Link | true |
| Link | https://www.tga.gov.au/safety/safety-monitoring-and-information/safety-alerts/natures-valley-collagen-builder-tablets |
| Pub Date | Mon, 16 Feb 2026 00:00:00 +1100 |
| Extracted category | drugs |
Check Other Products In Your Household
Free Safety ToolsSafety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:
Overview
- Recalling FirmTGA
- Risk LevelMedicines Safety Alert
- DistributionAustralia
📢 Share Warning
Alert family and friends to keep them safe. Copy this quick alert message:
🚨 SAFETY ALERT: TGA - Natures Valley Collagen Builder tablets Check if your household is affected: https://therecallfile.com/recalls/natures-valley-collagen-builder-tablets/AU-TGA-550084
Join Alertlist
Get instant email updates whenever critical safety recalls like this are published.
Related Recalls
UKMHRA Safety Roundup: July 2026
MHRA Safety Roundup: July 2026
Summary of the latest safety advice for medicines and medical device users...
UKClass 4 Medicines Defect Notification: Neuraxpharm UK Ltd, Tuzulby prolonged-release chewable tablets, EL(26)A/36
Class 4 Medicines Defect Notification: Neuraxpharm UK Ltd, Tuzulby prolonged-release chewable tablets, EL(26)A/36
Neuraxpharm UK Ltd has informed the MHRA of missing safety information in the Patient Information Leaflet (PIL) and Summary of Product Characteristics (SmPC) for certain batches of Tuzulby prolonged r...
FDA DrugsNystatin Cream USP, (100,000 USP Nystatin Units), NET WT 15 g, Rx only, 15 g tube, Manufactured by Padagis, Yeruham, Israel, NDC 45802-059-35
Nystatin Cream USP, (100,000 USP Nystatin Units), NET WT 15 g, Rx only, 15 g tube, Manufactured by Padagis, Yeruham, Israel, NDC 45802-059-35
Subpotent Drug: Low out of specification assay results performed during long-term stability testing.